Carboxymethyl Cellulose Sodium (CMC-Na) Market Intelligence Analysis (May 2026)

I. Core Market Data
1. Price Trends
- Detergent-grade medium-viscosity CMC (300 ± 50 mPa·s): Average ex-factory price was RMB 82,600/ton in 2025, adjusted slightly to RMB 83,900/ton in Q1 2026 (up 1.6%), reflecting a strategic shift from cost-driven pricing to value-driven structural optimization.
- Pharmaceutical-grade CMC: Average procurement price by domestic pharmaceutical enterprises was RMB 286/kg in 2025, up 3.2% year-on-year; high-end specifications (e.g., low-viscosity, ultra-low endotoxin grades) face structural supply shortages.
- Battery-grade CMC: International market remains dominated by Nouryon and Daicel; domestic enterprises are accelerating technological breakthroughs—e.g., GreenEnergy Fiber Materials has achieved advantages including uniform molecular weight distribution and low impurity levels via proprietary patented technologies.

2. Capacity and Output
- Detergent-grade CMC: National total capacity reached 186,000 tons/year in 2025, with actual output at 124,000 tons—capacity utilization rate of 66.7%; 11 enterprises exceeded 5,000 tons/year output, with CR4 (concentration ratio of top four) at 54.3%.
- Battery-grade CMC: Global market projected to reach USD 620 million by 2031, growing at a CAGR of 10% during 2026–2031; domestic players—including Fujian Meiya Rui and Lingguang Group—are rapidly expanding capacity and capabilities.

3. Regional Distribution
- East China region accounted for 47.3% of national detergent-grade CMC capacity in 2025, serving as the core industrial cluster; South China accounted for 22.1%; North China and Southwest China registered the fastest growth rates (up 18.6% and 15.4% year-on-year, respectively).
- Export markets: China’s CMC exports were substantial in 2023, primarily destined for Southeast Asia, the Middle East, and Africa; in 2025, the EU REACH regulation introduced mandatory notification requirements for residual chloroacetic acid monomer, increasing compliance costs for SME exporters by 18.7%.

II. Industry Drivers
1. Downstream Application Upgrades
- Detergents: Concentrated liquid laundry detergents captured 38.7% share in retail channels across East and South China in 2025, requiring 29.8% higher CMC dosage versus traditional powder formulations—fueling demand for premium products.
- Pharmaceuticals: In 2025, 41 new drug or generic drug approvals containing CMC were granted domestically; Class 2 improved-new-drug registrations under chemical drug categories explicitly designate CMC as a critical excipient; exploratory application of CMC as a lyoprotectant in mRNA vaccine freeze-drying has advanced to pilot-scale testing.
- New Energy: Rising demand for lithium-ion battery anode binders—global battery-grade CMC demand is projected to reach 48,000 tons by 2030; silicon-based anode binder demand surpassed 15,000 tons in 2024.

2. Policy and Environmental Pressures
- Domestic: Shandong Province offers a 150% super-deduction for R&D expenditures exceeding 5% of revenue; Zhejiang Province has established a vehicle-grade CMC pilot verification platform; China’s “General Rules for Carbon Footprint Accounting of Carboxymethyl Cellulose Sodium Products” is expected to be issued in 2026, mandating public disclosure of emissions data.
- International: The EU will require ≥90% biodegradability for CMC starting in 2027—potentially phasing out 10–15% of small- and medium-sized production capacity; the U.S. FDA has implemented virus clearance validation requirements for pharmaceutical-grade CMC, significantly raising technical entry barriers.

3. Technological Advancements
- Leading enterprises have upgraded production processes—replacing aqueous-phase methods with organic solvent-based synthesis and implementing real-time DS (degree of substitution) control systems using online laser Raman spectroscopy—to enhance product uniformity and purity.
- Shandong Heda has commissioned a pilot-scale (1,000-ton/year) bio-based CMC line using corn cob residue as feedstock, achieving 99.2% purity and ash content ≤0.3%, reducing wastewater COD load by 42% versus conventional routes.

III. Competitive Landscape Analysis
1. Market Concentration
- Detergent-grade CMC: CR4 stood at 54.3% in 2025, led by first-tier players—Lihong Fine Chemical, Shanghai Changguang, Changshu WeiYi Technology, and Yingte Chemical.
- Pharmaceutical-grade CMC: 27 enterprises hold regulatory filings; among them, 8 have U.S. FDA Drug Master File (DMF) registrations and 5 hold EU Certificates of a Suitability (CEP); Shandong Fufeng, Anhui Shanhe, Hunan Erkang, and Shaanxi Ruibo collectively account for 58.3% of the market.
- Battery-grade CMC: International leadership remains with Nouryon and Daicel; domestic firms are gaining ground—Anhui Shanhe and Shandong Ruifeng reported export order growth of 41.7% in 2025.

2. Corporate Strategies
- Leading enterprises: Strengthen competitive moats by deep integration with downstream clients (e.g., Procter & Gamble, Blue Moon, Hengrui Pharma) and securing international certifications (e.g., Kosher, Halal, SGS biodegradability reports).
- SMEs: Focus on niche applications—e.g., Zhejiang Jinfanda completed cycle-life testing of vehicle-grade CMC in lithium iron manganese phosphate (LFMP) battery systems, demonstrating ≥91.3% capacity retention after 2,000 cycles.

IV. Future Outlook and Recommendations
1. Price Trends
- Short-term: Detergent-grade CMC prices remain subject to upward pressure from refined cotton linter costs (average RMB 16,800/ton in 2025, +7.1% YoY) and environmental compliance investments—expecting moderate increases; pharmaceutical- and battery-grade CMC prices remain firm due to high technical barriers.
- Long-term: Bio-based raw material substitution and process optimization may gradually reduce production costs; however, premium products retain strong pricing power and margin resilience.

2. Demand Forecasts
- Detergents: Continued penetration of concentrated formulations is expected to drive CMC demand growth of 16.3% in 2026.
- Pharmaceuticals: Rapid expansion of the biopharmaceutical sector supports >8% annual compound growth in pharmaceutical excipient demand.
- New Energy: Growth in lithium battery shipments will sustain robust demand for battery-grade CMC, with a projected 2026–2031 CAGR of 10%.

3. Investment Risks and Opportunities
- Risks: Increasing regulatory stringency (e.g., EU biodegradability mandates), volatility in raw material prices, and accelerating technology obsolescence pressures.
- Opportunities: High-growth niches include bio-based CMC, ultra-high-purity pharmaceutical-grade CMC, and battery-specific binder formulations; vertically integrated enterprises—with capabilities spanning raw materials, manufacturing, and application R&D—hold significant competitive advantages.